Evidence map›Paper›PMID 42681368›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Polyclonal Antibody Selection of Partially Disulfide-Bonded Protein States.

Diego Butera, Philip J Hogg

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Diego ButeraSchool of Life Sciences, University of Technology Sydney and Centenary Institute, University of Sydney, Sydney, NSW, Australia.
Philip J HoggSchool of Life Sciences, University of Technology Sydney and Centenary Institute, University of Sydney, Sydney, NSW, Australia. p.hogg@centenary.org.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polyclonal antibodies are used extensively to characterize their protein antigens in many experimental settings, including measuring protein concentration and function in vitro, ex vivo and in fixed and living tissues. Disulfide bonds constrain the polypeptide backbone of proteins and reduce the conformational variations of the structure. Several proteins are constitutively produced as multiple partially disulfide-bonded states that result in populations of protein states with a variety of conformational forms, which can influence polyclonal antibody binding to the protein. For two protein antigens described herein, polyclonal antibodies preferentially recognize states with more unformed disulfides and the avidity of the antibodies correlates with extent of unformed disulfide bonds in one of the protein antigens. This selectivity of polyclonal antibodies for their target antigens should be considered when interpreting the results of antibody-based experiments.

Indexed as

AntibodiesDisulfidesProteinsAnimalsAntigensHumansProtein ConformationAntibodiesAntigensDisulfidesProteinsAntibodyCysteineDisulfide bondFibrinogenVon Willebrand factor

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.